Multiple Myeloma Coverage from Every Angle

Noopur S. Raje, MD, and Kenneth C. Anderson, MD, on Myeloma Bone: Updated Results on Anti-BCMA CAR T-Cell Therapy

Posted: Tuesday, August 15, 2017

Kenneth C. Anderson, MD, of Dana-Farber Cancer Institute, and Noopur S. Raje, MD, of the Massachusetts General Hospital Cancer Center, discuss new findings from the first-in-human multicenter study of bb2121 anti-BCMA CAR T-cell therapy for relapsed/refractory multiple myeloma.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.